Cargando…
Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
Glioblastoma (GBM) is the most aggressive primary brain tumor with poor prognosis. Here, we studied the effects of phenformin, a mitochondrial complex I inhibitor and more potent chemical analog of the diabetes drug metformin on the inhibition of cell growth and induction of apoptosis of glioma stem...
Autores principales: | Jiang, Wei, Finniss, Susan, Cazacu, Simona, Xiang, Cunli, Brodie, Ziv, Mikkelsen, Tom, Poisson, Laila, Shackelford, David B., Brodie, Chaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302927/ https://www.ncbi.nlm.nih.gov/pubmed/27486821 http://dx.doi.org/10.18632/oncotarget.10919 |
Ejemplares similares
-
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
por: Bier, Ariel, et al.
Publicado: (2013) -
RasGRP3 regulates the migration of glioma cells via interaction with Arp3
por: Lee, Hae Kyung, et al.
Publicado: (2015) -
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop
por: Giladi, Nis David, et al.
Publicado: (2015) -
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal
por: Lee, Hae Kyung, et al.
Publicado: (2013) -
RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK
por: Ziv-Av, Amotz, et al.
Publicado: (2015)